Cargando…
Oral Realgar-Indigo Naturalis Formula Treatment for Acute Promyelocytic Leukemia in Children: A Randomized, Control Clinical Trial
OBJECTIVE: To analyze the efficacy, safety, and economy of RIF compared with intravenous arsenic trioxide (ATO) for the induction and consolidation therapy of pediatric APL. MATERIALS AND METHODS: In this randomized control clinical trial (NCT02200978), children with newly diagnosed APL from June 20...
Autores principales: | Luo, Senlin, Tian, Jidong, Sun, Xiao, Wu, Feifeng, Liu, Ying, Wan, Wuqing, She, Zhou, Wen, Chuan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9276483/ https://www.ncbi.nlm.nih.gov/pubmed/35836830 http://dx.doi.org/10.1155/2022/8314176 |
Ejemplares similares
-
Oral Realgar-Indigo Naturalis Formula Plus Retinoic Acid for Acute Promyelocytic Leukemia
por: Lou, Yinjun, et al.
Publicado: (2021) -
Multicenter randomized trial of arsenic trioxide and Realgar‐Indigo naturalis formula in pediatric patients with acute promyelocytic leukemia: Interim results of the SCCLG‐APL clinical study
por: Yang, Ming‐Hua, et al.
Publicado: (2018) -
Traditional mineral medicine realgar and Realgar-Indigo naturalis formula potentially exerted therapeutic effects by altering the gut microbiota
por: Luo, Lu, et al.
Publicado: (2023) -
Clinical Study on Prospective Efficacy of All-Trans Acid, Realgar-Indigo Naturalis Formula Combined with Chemotherapy as Maintenance Treatment of Acute Promyelocytic Leukemia
por: Xiang-Xin, Li, et al.
Publicado: (2014) -
Treatment of non-high-risk acute promyelocytic leukemia with realgar-indigo naturalis formula (RIF) and all-trans retinoid acid (ATRA): study protocol for a randomized controlled trial
por: Zhang, Xinxin, et al.
Publicado: (2020)